Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of British Columbia

$105,000.00

Epigenetic Regulation of Microglia in Alzheimer's Disease

EF 2013-14

Résumé
Alzheimers Disease (AD) is the most common form of senile dementia, affecting approximately 500 000 people in Canada alone. It is a progressive neurodegenerative disease, causing loss of learning and memory, and eventually even the ability to sit upright, eat, or smile. Despite extensive research, causes of AD remain elusive. Recently, a theory has been proposed that neuron death in AD, and many other neurodegenerative diseases, is amplified by a loss of protection by microglia. Microglia are the immune cells of the central nervous system. They constantly survey the environment for infections and toxins, provide growth factors for neurons, and assist in tissue remodelling. However, like all replicating cells, microglia become less functional as they age and are then termed dystrophic microglia. Aging of other immune cells throughout the body can be regulated by how tightly their DNA is stored. Addition of chemical groups to the DNA-packaging proteins can either tighten or loosen the DNA, known as epigenetic regulation. There has been little research on epigenetic regulation in microglia. Therefore, I will determine if compounds that loosen DNA are capable of reverting aged microglia to a younger, more protective state, which can protect neurons from age-related damage. Firstly, cellular analyses will determine how DNA is packaged in young and aged microglia. I have access to healthy and AD tissue from both humans and rodents, which will help to clarify if dystrophic microglia appear before or after AD pathology, and if they develop in overlapping areas within the brain. I will also expose differences in young and aged microglial functions, and determine if altering DNA compaction can rescue dystrophic microglia and arrest learning impairment in rodent AD models. This research will contribute to knowledge on mechanisms of AD, and provide desperately-needed avenues for potential treatment and prevention of neurodegenerative disorders.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
314350
Name
York Elisa M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Epigenetic Regulation of Microglia in Alzheimer's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Epigenetic Aging; Microglia; Neurodegeneration
Abstract
Alzheimers Disease (AD) is the most common form of senile dementia, affecting approximately 500 000 people in Canada alone. It is a progressive neurodegenerative disease, causing loss of learning and memory, and eventually even the ability to sit upright, eat, or smile. Despite extensive research, causes of AD remain elusive. Recently, a theory has been proposed that neuron death in AD, and many other neurodegenerative diseases, is amplified by a loss of protection by microglia. Microglia are the immune cells of the central nervous system. They constantly survey the environment for infections and toxins, provide growth factors for neurons, and assist in tissue remodelling. However, like all replicating cells, microglia become less functional as they age and are then termed dystrophic microglia. Aging of other immune cells throughout the body can be regulated by how tightly their DNA is stored. Addition of chemical groups to the DNA-packaging proteins can either tighten or loosen the DNA, known as epigenetic regulation. There has been little research on epigenetic regulation in microglia. Therefore, I will determine if compounds that loosen DNA are capable of reverting aged microglia to a younger, more protective state, which can protect neurons from age-related damage. Firstly, cellular analyses will determine how DNA is packaged in young and aged microglia. I have access to healthy and AD tissue from both humans and rodents, which will help to clarify if dystrophic microglia appear before or after AD pathology, and if they develop in overlapping areas within the brain. I will also expose differences in young and aged microglial functions, and determine if altering DNA compaction can rescue dystrophic microglia and arrest learning impairment in rodent AD models. This research will contribute to knowledge on mechanisms of AD, and provide desperately-needed avenues for potential treatment and prevention of neurodegenerative disorders.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
York, Elisa M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~